“Use of Liraglutide in the Medicinal Therapeutic Approach of Non-Alcoholic Steatohepatitis (NASH)”. Research, Society and Development, vol. 10, no. 10, Aug. 2021, p. e389101018921, https://doi.org/10.33448/rsd-v10i10.18921.